Treatment algorithm of PTLD | ABVD, adriamycin/bleomycin/vinblastine/dacarbazine; CHOP, cyclophosphamide/doxorubicin/vincristine/prednisolone; CNI, calcineurin inhibitor; CNS, central nervous system; CR, complete remission; CTx, chemotherapy; HD MTX, high-dose methotrexate; mTOR, mammalian target of rapamycin; PTCL, peripheral T-cell lymphoma; RIS, reduction of immunosuppression; RTx, radiation therapy. | Ligeti, K., Müller, L. P., Müller-Tidow, C., & Weber, T. (2017). Risk factors, diagnosis, and management of posttransplant lymphoproliferative disorder: improving patient outcomes with a multidisciplinary treatment approach. Transplant Research and Risk Management, Volume 9, 1–14.

Leave a Reply